Legal Opinion
Med. Diagnostic Labs., L. L.C. v. Protagonist Therapeutics, Inc.
District Court, N.D. California
Decided February 7, 2018No. Case No. 17–cv–05572–EMCPublishedCited by 3 opinions
1Opinion of the Court
EDWARD M. CHEN, United States District Judge
Plaintiff Medical Diagnostics Labs alleges that Defendant Protagonist Therapeutics, Inc.'s development of a drug called PTG-200 infringes on its patent for polypeptides that bind to IL-23 receptors. These polypeptides, including PTG-200, have therapeutic potential to treat inflammatory and autoimmune diseases. Protagonist has entered into a multi-million dollar agreement with third-party pharmaceutical company Janssen, Inc. to develop the drug, perform testing necessary for regulatory approval, seek regulatory approval, and, if regulatory approval…
2Cases cited13 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Maryland Casualty Co. v. Pacific Coal & Oil Co.Supreme Court of the United States · 1941
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
- 98 Cal. Daily Op. Serv. 291, 98 Daily Journal D.A.R. 398 Government Employees Insurance Company v. Alexander Dizol, Special Administrator of the Estate of Kevin Tate Dizol, DeceasedCourt of Appeals for the Ninth Circuit · 1998
- Benitec Australia, Ltd. v. Nucleonics, Inc.Court of Appeals for the Federal Circuit · 2007
8 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Allele Biotechnology and Pharmaceuticals, Inc. v. Pfizer, Inc.District Court, S.D. California · 2021
- Edwards Lifesciences Corporation v. Meril Life Sciences Pvt. Ltd.District Court, N.D. California · 2020
- UCB, Inc. v. Catalent Pharma Solutions Inc.District Court, E.D. Kentucky · 2021